Literature DB >> 20325300

Chemotherapy in Hodgkin's Disease.

R Lindan.   

Abstract

Entities:  

Year:  1956        PMID： 20325300      PMCID： PMC1824448     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

2.  Chemotherapy of leukemia. V. Effects of 2,4,6-triethylenimino-S-triazine and related compounds on transplanted mouse leukemia.

Authors:  J H BURCHENAL; S F JOHNSTON; M A CREMER; L F WEBBER; C C STOCK
Journal:  Proc Soc Exp Biol Med       Date:  1950-08

3.  New cytotoxic agents with tumour-inhibitory activity.

Authors:  F L ROSE; J A HENDRY; A L WALPOLE
Journal:  Nature       Date:  1950-06-24       Impact factor: 49.962
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.